Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-(Bromomethyl)-3-methylquinoxaline is a chemical compound with the molecular formula C10H9BrN2. It is a quinoxaline derivative that contains a bromomethyl group and a methyl group. This chemical is commonly used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. Its properties make it suitable for use in organic synthesis and as a building block in the creation of new and complex molecules. Additionally, 2-(Bromomethyl)-3-methylquinoxaline has applications in research and development, particularly in the field of medicinal chemistry, due to its potential pharmacological properties. Overall, this chemical compound plays an important role in various industries and scientific endeavors.

5320-95-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 5320-95-6 Structure
  • Basic information

    1. Product Name: 2-(BROMOMETHYL)-3-METHYLQUINOXALINE
    2. Synonyms: 2-(BROMOMETHYL)-3-METHYLQUINOXALINE
    3. CAS NO:5320-95-6
    4. Molecular Formula: C10H9BrN2
    5. Molecular Weight: 237.0959
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 5320-95-6.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 306°Cat760mmHg
    3. Flash Point: 138.9°C
    4. Appearance: /
    5. Density: 1.522g/cm3
    6. Vapor Pressure: 0.00143mmHg at 25°C
    7. Refractive Index: 1.663
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: 2-(BROMOMETHYL)-3-METHYLQUINOXALINE(CAS DataBase Reference)
    11. NIST Chemistry Reference: 2-(BROMOMETHYL)-3-METHYLQUINOXALINE(5320-95-6)
    12. EPA Substance Registry System: 2-(BROMOMETHYL)-3-METHYLQUINOXALINE(5320-95-6)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 5320-95-6(Hazardous Substances Data)

5320-95-6 Usage

Uses

Used in Pharmaceutical Industry:
2-(Bromomethyl)-3-methylquinoxaline is used as a chemical intermediate for the synthesis of various pharmaceuticals. Its unique structure allows for the creation of new and complex molecules with potential therapeutic applications.
Used in Agrochemical Industry:
2-(Bromomethyl)-3-methylquinoxaline is used as a building block in the development of agrochemicals, contributing to the creation of new compounds with potential applications in agriculture.
Used in Organic Synthesis:
2-(Bromomethyl)-3-methylquinoxaline is used as a reagent in organic synthesis, enabling the formation of a wide range of organic compounds with diverse properties and applications.
Used in Research and Development:
2-(Bromomethyl)-3-methylquinoxaline is used as a research compound in the field of medicinal chemistry, where its potential pharmacological properties are explored and utilized for the development of new drugs and therapeutic agents.

Check Digit Verification of cas no

The CAS Registry Mumber 5320-95-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,3,2 and 0 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 5320-95:
(6*5)+(5*3)+(4*2)+(3*0)+(2*9)+(1*5)=76
76 % 10 = 6
So 5320-95-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H9BrN2/c1-7-10(6-11)13-9-5-3-2-4-8(9)12-7/h2-5H,6H2,1H3

5320-95-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(bromomethyl)-3-methylquinoxaline

1.2 Other means of identification

Product number -
Other names 2-bromomethyl-3-methylquinoxaline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5320-95-6 SDS

5320-95-6Relevant articles and documents

Versatile Heteroleptic Cu(I) Complexes Based on Quino(xa)-line-Triazole Ligands: from Visible-Light Absorption and Cooperativity to Luminescence and Photoredox Catalysis

Bruschi, Cecilia,Gui, Xin,Salaeh-arae, Nasrin,Barchi, Tobia,Fuhr, Olaf,Lebedkin, Sergei,Klopper, Wim,Bizzarri, Claudia

, p. 4074 - 4084 (2021/08/27)

Four new heteroleptic Cu(I) complexes based on 1, 2, 3-triazolyl-quinoline or quinoxaline and a chelating diphosphine were prepared and fully characterised. The mononuclear derivatives absorb in the visible region, up to 600 nm, while the dinuclear complex has a long-tail absorption up to 800 nm, showing an additional electronic state corroborated by theoretical calculations. Although a methylene group between the triazole and the quino(xa)line moiety increases the bite angle and decreases the luminescence in solution, all complexes emit brightly in the solid-state. Their redox properties in the excited state were determined, proving their ability in serving as photoredox catalysts in atom transfer radical addition successfully.

Optimisation of conoidin A, a peroxiredoxin inhibitor

Liu, Gu,Botting, Catherine H.,Evans, Kathryn M.,Walton, Jeffrey A. G.,Xu, Guogang,Slawin, Alexandra M. Z.,Westwood, Nicholas J.

scheme or table, p. 41 - 45 (2010/11/02)

Lead optimisation: Interest in the inhibition of peroxiredoxin has been revitalised by their recently identified role in signalling cascades. Here, the synthesis and analysis of novel analogues of the peroxiredoxin inhibitor conoidin A is described. Computational methods are used to rationalise the generated SAR data. These studies lead to a proposed binding mode for this class of compounds that will aid the design of second generation inhibitors. (Figure Presented)

Photochemistry of benzene and quinoxaline fused Δ2-1,2,3-triazolines and their trapping products

Chen, Yu-Jen,Hung, Hao-Chih,Sha, Chin-Kang,Chung, Wen-Sheng

experimental part, p. 176 - 182 (2010/03/04)

The benzene and quinoxaline fused Δ2-1,2,3-triazolines 1a and 1b were synthesized in good yields using Knoevenagel condensation and intramolecular 1,3-dipolar cycloaddition as two of the key reactions. Photolysis (254 nm) of Δ2-1,2,3-triazoline 1a or 1b in acetonitrile led to the homolytic cleavage of nitrogen that generated diethyl diazomalonate 7, highly reactive intermediates aziridines 8a,b, and isoindoles B. The latter two species subsequently underwent rearrangement to give the nitrogen extrusion products 9a,b, and polymers. Furthermore, the reactive intermediates were trapped by dienophiles to give the corresponding cycloadducts. Subsequent rearrangement of the N-bridged cycloadducts gave N-substituted pyrrolo[3,4-b]quinoxalines 12b and 15b in 6% and 9% yields, respectively. Irradiation of 1a in the presence of fumaronitrile led to the isolation of cycloadduct 16a with retention of stereochemistry. Thermal reaction of 1b gave more nitrogen extruded product 9b (58-63% yield) than that by photolysis (5-23% yield), which implied that zwitterionic intermediate might be involved in the former.

A simple and convenient manganese dioxide oxidation of benzyl halides to aromatic aldehydes under neutral condition

Goswami, Shyamaprosad,Jana, Subrata,Dey, Swapan,Adak, Avijit Kumar

, p. 194 - 195 (2007/10/03)

A simple, convenient and inexpensive benzylic oxidation reaction of arylmethylhalides under neutral conditions by manganese dioxide to the corresponding aldehydes has been described. Copyright

Synthesis and Selective Class III Antiarrhythmic Activity of Novel N-Heteroaralkyl-Substituted 1-(Aryloxy)-2-propanolamine and Related Propylamine Derivatives

Butera, John A.,Spinelli, Walter,Anantharaman, Viji,Marcopulos, Nicholas,Parsons, Roderick W.,et al.

, p. 3212 - 3228 (2007/10/02)

The synthesis and biological evaluation of a series of novel 1-(aryloxy)-2-propanolamines and several related deshydroxy analogues are described.Compounds 4-29 were prepared and investigated for their class III electrophysiological activity in isolated canine Purkinje fibers and in anesthetized open-chest dogs.None of these compounds showed any class I activity.On the basis of the in vitro data, structure-activity relationships for the series are discussed.Two compounds, N-propoxy>phenyl>methanesulfonamide (12, WAY-123,223) and N-phenoxy>propyl>amino>methyl>-6-quinolinyl>methanesulfonamide (24, WAY-125,971) were identified and characterized as potent and specific class III antiarrhythmic agents in vitro and in vivo.Compound 12 was found to be orally bioavailable, to produce large increases of ventricular fibrillation threshold (VFT), and, in some instances, to restore sinus rhythm from ventricular fibrillation in anesthetized open-chest dogs at a dose of 5 mg/kg (iv).The enantiomers of 12 (i.e., 13 and 14) were synthesized and were found to exhibit similar electrophysiological effects in the Purkinje fiber screen.Compound 24, a propylamine analogue with potency and efficacy comparable to those of UK-68798 (2) and E-4031 (3), was studied in voltage-clamp experiments (isolated cat myocytes) and was found to be a potent and specific blocker of the delayed rectifier potassium current (IK).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5320-95-6